
Komodo Health Introduces MapLab™: An Integrated Solution for Healthcare and Life Sciences Insights
Komodo Health, a leader in healthcare data analytics, has unveiled MapLab™, a comprehensive offering designed to provide healthcare and Life Sciences organizations with robust insights into disease trends, treatment pathways, patient populations, and various complex research questions. This innovative technology is set to streamline the process of uncovering critical insights, ultimately contributing to the reduction of disease burden on a larger scale. MapLab is underpinned by advanced data science tools, customizable analytics dashboards, and a generative AI analytic assistant, all delivered through a unified, enterprise-wide platform powered by Komodo’s real-world patient data. Komodo’s data applications utilize data sets incorporating 330 million patients, 15 million new clinical encounters daily, 150 million payer complete profiles, data from 350 hospitals, and 11 billion lab records to offer insight into real world trends.
Arif Nathoo, CEO and Co-Founder of Komodo Health, commented on MapLab’s significance, stating, “MapLab represents the most powerful AI-fueled insights engine available in the market, and we’re putting that directly into the hands of our customers. Progress in healthcare has been hampered by fragmented data scattered throughout the enterprise, disconnected analytic tools, and the absence of a reliable, flexible platform for insight generation. With MapLab, we’re delivering a scalable, connected healthcare intelligence experience that the entire enterprise can use.”
MapLab offers an array of capabilities for Life Sciences and healthcare companies including the ability to automate common analytic tasks and accelerate their impact by leveraging a library of pre-built content curated by Komodo experts. These resources include analytic templates, codesets, and dashboards, simplifying patient-cohort exploration, analysis, and insight generation. The platform also allows organizations to combine datasets aligned with their priorities and therapeutic areas. By connecting Komodo’s Healthcare Map™, which houses comprehensive and accurate de-identified patient-level data in the U.S., with isolated data lakes and proprietary patient-level data sources, users can gain deeper insights into patient populations, treatment pathways, outcomes, and disease trends. Finally, Komodo provides an integrated development environment for data scientists and engineers to build the next generation of Life Sciences solutions. This environment enables users to harness de-identified patient-level data in a secure, flexible, cloud-based setting, using programming languages and frameworks of their choice to develop new applications, APIs, and algorithms.
The first module of MapLab is set to become generally available in Q4 2023, with additional modules planned for early 2024. As the MapLab environment continues to expand, users will also gain access to a generative AI analytics assistant, offering rapid insights and information contextualized to unique business needs. This AI copilot leverages Komodo’s platform services and pre-trained large language models to enhance productivity and accelerate user impact, benefiting individuals both within and outside the MapLab environment.